Sanofi's Dupixent Cleared For Children With Atopic Dermatitis In EU
Only Biologic Approved For 6 to 11 Year-Olds
Executive Summary
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.